New Cannabis Screening Criteria
16 November 2020
With the rise in investment opportunities in the legal cannabis market, we at Ethical Screening are pleased to introduce new Cannabis screening criteria to our Company Ethics Database, allowing investors and managers to screen their investments based on cannabis-related activities.
As we've discussed previously, investors may have a variety of motivations for wishing to avoid investment in companies with involvement in cannabis, from environmental, moral and legal, to social justice issues. We have therefore separated involvement into cannabis-related products for medical purposes, and cannabis-related products for recreational purposes.
This approach allows investors to exclude all companies growing, manufacturing or processing cannabis products intended for recreational use (products containing THC only), such as inhalants, food items or beverages; and/or companies manufacturing or supplying cannabis products for medical use (mainly pharmaceutical products). We have also made a distinction between companies with a major (in terms of revenue or significance to the industry as a whole) or minor involvement.
Existing subscribers to the Company Ethics Database service can log in now to use the criteria in practice. Non-subscribers please contact us for further information.
Raechel Kelly - Communications Manager
16/11/2020
◀ Back to news